Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET
NCT05654675
Summary
The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are: * Is the new quantification method superior with respect to the method currently used in the clinic? * Does the new quantification method provide accurate assessment of the sugar consumption of tumours? Participants who will undergo a standard care FDG PET/CT scan will in additional receive a dynamic PET/CT scan prior to the standard care scan. In addition blood samples will be drawn at three time points during the examination.
Eligibility
Inclusion Criteria: * Patients who receive an 18F FDG PET/CT scan as part of standard care * Be competent and be 18 years of age or older Exclusion Criteria: * Diabetes (fasted blood glucose \> 7 mmol/L) * Not fasted \> 4 hours * Physical exercise within 24 hours * Earlier treatment for carcinoma with radio/chemo-therapy * Active inflammation (fever \> 38 degrees, CRP \> 5) * Any condition or medical indication (such as claustrophobia) that indicates that the patient will not be able to lie still for the duration of the dynamic PET/CT examination * Pregnant or breast feeding
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05654675